Related Experiment Video

Updated: Jun 13, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Blood glucose control and coronary heart disease

Cristina Bianchi1, Giuseppe Penno, Roberto Miccoli

  • 1Section of Metabolic, Diseases and Diabetes, Department of Endocrinology and Metabolism, University of Pisa, Pisa, Italy.

Herz
|May 15, 2010
PubMed

Insights

Hyperglycemia, or high blood sugar, is linked to cardiovascular disease. While tight glycemic control in type 2 diabetes shows mixed results, individualized therapy is key for managing this risk.

Area of Science:

  • Cardiology
  • Endocrinology
  • Metabolic Diseases

Background:

  • Epidemiologic data indicate a direct link between hyperglycemia and cardiovascular disease (CVD).
  • Glycemia acts as a continuous variable, similar to other CVD risk factors, without a clear threshold.
  • Elevated plasma glucose activates atherogenic mechanisms, contributing to cardiovascular risk.

Purpose of the Study:

  • To review the relationship between hyperglycemia and cardiovascular disease.
  • To examine the impact of glycemic control interventions on cardiovascular outcomes.
  • To discuss current strategies for managing hyperglycemia-related cardiovascular risk.

Main Methods:

  • Review of epidemiologic data and large-scale intervention trials (e.g., ACCORD, ADVANCE, VADT).
  • Analysis of the role of glycemia as a continuous cardiovascular risk factor.
  • Discussion of mechanisms linking hyperglycemia to atherogenesis.

Main Results:

  • Intervention trial results on tight glycemic control in type 2 diabetes are controversial.
  • Early and near-normal glycemic control may be more beneficial, especially during acute coronary events.
  • Individualized therapy approaches are crucial for reducing hyperglycemia-associated cardiovascular risk.

Conclusions:

  • Hyperglycemia is a significant cardiovascular risk factor, acting through multiple atherogenic pathways.
  • The effectiveness of strict glycemic control is debated, with evidence suggesting benefits from earlier and individualized management.
  • Personalized therapeutic strategies are essential for mitigating cardiovascular risks in patients with hyperglycemia.

More Related Videos

Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice07:35

Hyperglycemic Clamp and Hypoglycemic Clamp in Conscious Mice

Published on: January 26, 2024

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...